JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mu, D.
Right arrow Articles by Sancar, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mu, D.
Right arrow Articles by Sancar, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 272, Number 46, Issue of November 14, 1997 pp. 28971-28979

Characterization of Reaction Intermediates of Human Excision Repair Nuclease*

(Received for publication, June 30, 1997, and in revised form, September 10, 1997)

David Mu Dagger , Mitsuo Wakasugi , David S. Hsu and Aziz Sancar §

From the Department of Biochemistry and Biophysics, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599-7260

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES


ABSTRACT

Nucleotide excision repair in humans is a complex reaction involving 14 polypeptides in six repair factors for dual incisions on either sides of a DNA lesion. To identify the reaction intermediates that form by the human excision repair nuclease, we adopted three approaches: purification of functional DNA·protein complexes, permanganate footprinting, and the employment as substrate of presumptive DNA reaction intermediates containing unwound sequences 5' to, 3' to, or encompassing the DNA lesion. The first detectable reaction intermediate was formed by substrate binding of XPA, RPA, XPC·HHR23B plus TFIIH (preincision complex 1, PIC1). In this complex the DNA was unwound on either side of the lesion by no more than 10 bases. Independent of the XPG nuclease function, the XPG protein stabilized this complex, forming a long lived preincision complex 2 (PIC2). The XPF·ERCC1 complex bound to PIC2, forming PIC3, which led to dual incisions and the release of the excised oligomer. With partially unwound DNAs, thymine cyclobutane dimer was excised at a fast rate independent of XPC·HHR23B, indicating that a major function of this protein is to stabilize the unwound DNA or to aid lesion unwinding in preincision complexes.


INTRODUCTION

In humans, nucleotide excision repair is the sole DNA repair activity for removing bulky adducts. The repair reaction involves two basic steps, damage excision by dual incisions and repair synthesis. Mutations that interfere with damage excision give rise to xeroderma pigmentosum (XP)1 (1).

XP is genetically heterogeneous; mutations in seven genes, XPA through XPG, may give rise to the disease (see Ref. 2). Important progress has been made in recent years in understanding the molecular basis of XP and the roles of XP proteins in nucleotide excision repair. These studies have culminated in reconstitution of repair activity in vitro using purified repair proteins (for review, see Refs. 3 and 4). From these biochemical experiments it was concluded that the minimal set for damage removal activity (i.e. excision nuclease) is composed of six repair factors. They are XPA, TFIIH (which includes XPB and XPD), XPC·HHR23B, XPG, XPF·ERCC1, and RPA (5, 6). Evolutionarily and structurally related proteins perform the same function in the highly homologous Saccharomyces cerevisiae in vitro system (7, 8).

In addition to identifying all of the proteins for excision nuclease activity, recent studies have also characterized the individual repair factors and their interactions with one another and with DNA in considerable detail. XPA and RPA, or a complex of the two, has been implicated in damage recognition (9-13). TFIIH has a bidirectional DNA helicase activity conferred by its XPB and XPD subunits (14-18). XPG has a DNA cutting activity specific for the junction of single-stranded DNA to double-stranded DNA in the 5' to 3' direction (19, 20); XPF·ERCC1 has a DNA junction cutting activity opposite to that of XPG (20-22). XPC·HHR23B binds to DNA with high affinity (23, 24) and is dispensable for excising certain lesions (6) and all lesions immediately 5' to a run of 10 mismatched base pairs (Ref. 25 and data not shown). In addition to these functional properties of the repair factors, protein-protein interactions among the various factors have been investigated. XPA binds to XPF·ERCC1 (26-28) and with lower affinity to TFIIH (29). TFIIH binds XPG with high affinity (5, 30) and XPC with lower affinity (16). Finally, RPA binds to XPF·ERCC1 and to XPA (12). These structural and functional properties of the repair factors have led to the proposal of models on assembly and catalysis by excision nuclease. However, no specific intermediates have been detected with either gel retardation or footprinting techniques in support of the reaction mechanism models.

In this investigation, we set out to study the events taking place from the damage recognition step to the release of the damage in an oligonucleotide. Specifically, we wished to detect the excision reaction intermediates of repair protein-DNA complexes and the conformation of DNA within these complexes. Using a biotin-tagged substrate and purified repair factors, we show that the first protein-DNA complex detectable by the streptavidin pull-down assay requires XPA, RPA, XPC·HHR23B, and TFIIH proteins as well as ATP hydrolysis. This complex is termed Preincision Complex 1 (PIC1). PIC1 is relatively unstable and forms a tighter, more stable complex called Preincision Complex 2 (PIC2) in the presence of XPG, even when XPG has lost its 3'-junction nuclease activity because of an active-site mutation. XPF·ERCC1 does not bind to PIC1, but it does bind to PIC2 containing either wild-type or mutant XPG. We call the complex that forms with all six repair factors PIC3. When PIC3 contains the active-site mutant XPG, only the 5'-incision is made by this complex (31). However, when the complex is formed with wild-type XPG, it immediately leads to dual incision and release of the excised oligomer of 24-32 nucleotides in length. Permanganate footprinting reveals that in PIC1, the DNA is unwound on both sides of the lesion by 5-10 nucleotides. In PIC2, the unwound region remains the same length as in PIC1 but becomes more stable. PIC3 does not promote further unwinding but leads to dual incisions that expose a 24-32-nucleotide region in the strand complementary to the damaged strand to permanganate modification. Using model substrates containing mispaired DNA 3', 5' or 3' and 5' to the lesion, it was confirmed that lesion unwinding is on the reaction pathway and that the main function of XPC·HHR23B is to aid in DNA unwinding.


MATERIALS AND METHODS

Repair Factors

Recombinant XPA (10, 32), RPA (33), and XPG (20) were isolated as described. TFIIH and XPC·HHR23B were purified from HeLa cells according to Mu et al. (5, 6). The point mutant of XPG (XPG-D812A) was prepared as described (31).

Pull-down Experiments

We used a 136-base pair duplex with a T[6-4]T photoproduct. The complete nucleotide sequence of the T[6-4]T substrate is identical to the T[6-4]T substrate employed previously (34) except that the 5'-terminal guanine of the T[6-4]T-containing strand was replaced by a cytosine in this study. The oligonucleotide containing a site-specific photoproduct (5'-GTAT[6-4]TATG-3') was provided by X. Zhao and was prepared by the method of Smith and Taylor (35). This oligomer was 5'-phosphorylated with [gamma -32P]ATP (7,000 Ci/mmol, ICN) using T4 kinase and annealed with other five partially overlapping oligonucleotides. After ligation, the full-length 136-mer with an internal 32P label at the fourth phosphodiester bond 5' to T[6-4]T was purified through an 8% denaturing and a 5% nondenaturing polyacrylamide gel. Since the substrate has a protruding guanine and a cytosine at either 3'-end, dGTP and biotinylated dCTP were used to fill in the one-base protruding ends, resulting in the biotinylation of the 3'-terminus of the T[6-4]T-containing strand. Subsequently, the biotinylated substrate DNA was incubated with streptavidin covalently linked to magnetic beads (Dynabead M-280, Dynal) and became linked to magnetic beads. Following pulling down using a magnet, the substrate was ready for the pull-down experiments.

As illustrated in Fig. 1, the pull-down experiments were initiated by incubating a subset of the six excision nucleases constituents and the magnetic bead-attached substrate (50 fmol) in 25 µl of excision reaction buffer (30 mM Hepes-KOH, pH 7.9, 50 mM KCl, 4 mM MgCl2, 200 µg/ml bovine serum albumin) with or without 2 mM ATP at 30 °C for 60 min. The substrate DNA was then pulled down by holding a magnet beneath the reaction vial and washed twice with 100 µl of excision reaction buffer containing 2 mM ATP to remove loosely bound proteins. The washed DNA pellet was then resuspended in 25 µl of excision reaction buffer with 2 mM ATP containing the repair proteins that were omitted in the first pull-down incubation and incubated at 30 °C for 90 min. To examine if dual incisions had occurred in this second incubation, the reaction mixture was deproteinized, ethanol-precipitated, and analyzed using an 8% denaturing polyacrylamide gel.


Fig. 1. Scheme for the pull-down experiments used to detect functional subcomplexes of repair factors and substrate DNA. The various shaped symbols indicate the individual repair factors, and the asterisks show the positions of the radiolabel.

[View Larger Version of this Image (27K GIF file)]


Permanganate Probing for Single-stranded Thymines in the Reaction Intermediates

The protocol of permanganate footprint method was adapted from Refs. 36 and 37. The 5'-terminally 32P-labeled T[6-4]T substrate was incubated with the indicated amounts of repair proteins at 30 °C for 60 min in excision reaction buffer with 2 mM ATP in a total volume of 25 µl. Subsequently, KMnO4 was added to a final concentration of 5 mM. After 1 min at room temperature, beta -mercaptoethanol was supplemented to 1 M to stop the permanganate reaction. Following deproteinization by proteinase K and ethanol precipitation, the DNA was resuspended in 50 µl of 1 M piperidine and incubated at 90 °C for 10 min. After evaporation under vacuum to remove piperidine, the permanganate-modified thymines were revealed by resolving the DNA products on 8% denaturing polyacrylamide gels.

Bubble Substrates Mimicking Unwound Intermediates

Internally 32P-labeled bubble substrates containing T<>T were synthesized as described by Mu and Sancar (25). The 32P label was in the fourth phosphodiester bond 5' to the photodimer. The sequences of oligonucleotides 1-7 (as indicated in Fig. 9A) used to construct the substrates have been published (25); oligonucleotides 8 and 9 are listed in Table I. The excision reactions of these bubble substrates were performed in the absence of the indicated repair factor under reaction conditions reported by Mu and Sancar (25). All excision reactions were processed as described above and resolved on 8% denaturing polyacrylamide gels. The levels of damage excision were quantified by scanning the dried polyacrylamide gels using PhosphorImager (Molecular Dynamics).


Fig. 9. Model substrates mimicking reaction intermediates of excision nuclease. Panel A, substrate constructs. Oligonucleotides used to construct these substrates are indicated by the # sign, and the position of a 32P radiolabel in each substrate is shown. The sequences of oligomers 1-7 have been published (25). Oligomers 8 and 9 are listed Table I. Panel B, internally radiolabeled substrates as shown in panel A were incubated either with the entire set of excision nuclease components or with partial mixtures with the indicated omissions. The reaction products generated by dual incisions of the excision nuclease are indicated by a bracket. Reactions similar to those in lanes 1-5 and 11-15 have been published previously (25). To reveal the weak signal in the absence of TFIIH, a longer exposure to an x-ray film of the area covering the excision products in lanes 17-20 is shown in lanes 21-24. The percents of substrate excised were: lane 2, 1.5%; lanes 7 and 9, 4.9%; lanes 12 and 14, 5.4%; lanes 17 and 19, 2.9%.

[View Larger Version of this Image (41K GIF file)]


Table I. Oligonucleotides (5' to 3') used to assemble bubble-containing model substrates in this study

Mismatched nucleotides in oligonucleotides 8 and 9 are underlined. The sequences of oligonucleotides 1-7 have been published (25).

Oligonucleotide no. Nucleotide sequence

8 GGGGCGAATTCGAGCTCGCCCGGGATCCTCTAGAGTCGACCTGCTGCAGCCCAAGCTTGGCGCTCCATACCCTCGCAAA TGGCCAGCTGGCGCAGATCTGGCTCGAGGATATCGAATTCCGTACGTGTTCAGGTCC
9 GGGGCGAATTCGAGCTCGCCCGGGATCCTCTAGAGTCGACCTGCTGCAGCCCAAGCTTGCGCGAGGTATCCCTCGCAAA TGGCCAGCTGGCGCAGATCTGGCTCGAGGATATCGAATTCCGTACGTGTTCAGGTCC


RESULTS

To study the assembly of human excision nuclease we used the following general strategy (Fig. 1). Individual repair proteins or combinations of them were mixed with a magnetic bead-linked substrate, and then the DNA and DNA-bound proteins were isolated using a magnet. To the purified DNA·protein complexes, the remaining repair factors were added, and repair was measured by the excision assay. In preliminary experiments we failed to isolate complexes with one to three repair factors and proceeded to conduct experiments with combinations of four and five repair factors. We were able to isolate complexes with four and five repair factors which we named Preincision Complex 1 and 2, respectively. These complexes are most likely on the pathway for formation of excision nuclease complex because they can lead to dual incisions upon encountering the missing components.

PIC1

Results of pull-down experiments conducted with two factor omissions are shown in Fig. 2. As apparent the only two-factor omission that produced a nucleoprotein complex purifiable by the pull-down assay is the one formed in the absence of XPF·ERCC1 and XPG proteins (Fig. 2, lane 2). All other pull-down experiments involving pairwise omissions of repair factors failed to produce excision products (data not shown). The formation of this complex (named PIC1) with XPA, RPA, XPC·HHR23B, and TFIIH is ATP-dependent (compare lanes 2 and 3). Most importantly, the addition of the XPG and XPF·ERCC1 nucleases to buffer-washed PIC1 resulted in the dual incision typical of human excision nuclease, indicating that the first four factors formed a structure conducive to assembly of active excision nuclease. Hence it is reasonable to conclude that the complex formed with these four repair factors is on the pathway to dual incision.


Fig. 2. Detection of PIC1 and 2. Human excision nuclease reconstituted in the absence of XPG and XPF·ERCC1 was subjected to the pull-down reaction with (lane 2) and without (lane 3) ATP (2 mM). After washing the pellet, the pulled down material was mixed with purified XPG and XPF·ERCC2 in 25 µl of excision reaction buffer with 2 mM ATP and incubated at 30 °C for 90 min. The reaction products were resolved on an 8% denaturing polyacrylamide gel. A standard excision reaction containing the full set of excision nuclease components and the magnetic bead-attached substrate without being subjected to the pull-down procedure is shown in lane 5. Excision products are indicated by a bracket. Extensive uncoupled 3'-incisions were observed with this bead-attached substrate as indicated. Lane 1 shows a pull-down reaction in the absence of repair proteins. The percents of substrate excised were: lanes 1 and 3, undetectable; lane 2, 0.6; lane 4, 3.1; lane 5, 6.7.

[View Larger Version of this Image (30K GIF file)]


PIC2

Previously, we reported that with the pull-down assay a preincision complex could be isolated from an XPF mutant cell extract, which upon incubation with purified XPF·ERCC1 protein led to excision of damage (6). However, pull-down experiments with a rodent XP-G mutant cell extract failed to yield a productive preincision complex, suggesting a role for XPG in the preincision events (6). This previous result with the rodent XP-G mutant cell extract seemed to be contradictory with the present data shown in Fig. 2 (lane 2), which indicates that a productive preincision complex (i.e. PIC1) can be formed in the absence of both XPG and XPF·ERCC1. Hence, we conducted single factor omission experiments using purified proteins. The results in Fig. 2 (lane 4) show that in the absence of XPF·ERCC1, a productive complex (designated PIC2) must have been pulled down from the mixture of XPA, RPA, TFIIH, XPC·HHR23B, and XPG so that its subsequent encounter with purified XPF·ERCC1 led to damage excision. The excision was not caused by nonspecific association of repair factors with substrate DNA because all other single omission experiments failed to give dual incisions under these conditions (see Fig. 3). As in the case of PIC1, the formation of this second preincision complex, PIC2, was also ATP-dependent (data not shown). In light of the results of the pull-down experiments using purified proteins, it is very likely that PIC1 may have been pulled down from the rodent XP-G mutant cell extract. Since in that study only the purified XPG protein was added back to the buffer-washed PIC1 (6), dual incisions failed to occur because of the absence of XPF·ERCC1 in the second incubation.


Fig. 3. Formation of the PIC2 is independent of XPF·ERCC1. The human excision repair factors minus the indicated component were incubated with an internally 32P-labeled T[6-4]T substrate attached to magnetic beads in 25 µl of excision reaction buffer with 2 mM ATP (lanes 2-7). Following pull-down and washing, the magnetic bead-bound material was resuspended in 25 µl of excision reaction buffer containing 2 mM ATP and the repair protein omitted in the pull-down incubation. The reaction products were resolved on an 8% denaturing polyacrylamide gel. The products of the dual incisions flanking the lesion as a result of the excision nuclease activity are indicated by a bracket. Lane 1 contained 50 fmol of substrate DNA that had been processed as in lanes 2-7 in the absence of any repair proteins. The percents of substrate excised were: lanes 1-5 and 7, undetectable; lane 6, 1.6.

[View Larger Version of this Image (35K GIF file)]


Significantly, comparison of the excision signals in XPG/XPF·ERCC1 and XPF·ERCC1 omission experiments shown in Fig. 2 and in repeated experiments conducted under identical conditions indicated that the excision signal obtained with PIC2 is much stronger than that obtained with PIC1. The most likely explanation is that PIC2 is more stable than PIC1 and better survives the repeated washes during pull-down so that upon addition of the omitted factor efficient excision takes place. This interpretation was supported by the experiments that probed the structure of DNA within these complexes as described below.

Conformation of DNA in PIC1 and PIC2

The dependence of formation of PIC1 and PIC2 on ATP and the fact that TFIIH has helicase activity (15-17) suggested that the DNA within these complexes might be unwound and that either the degree of unwinding or the protein composition of the unwound complex may be responsible for the differential stability of these complexes. Hence, we probed the DNA for unwinding within these complexes by KMnO4 treatment, which oxidizes unpaired thymines and renders them cleavable by alkali treatment.

The substrate was a duplex of 136 base pairs with a centrally located T[6-4]T and a terminal radiolabel in the complementary strand. Fig. 4 indicates the positions of Ts near the lesion in both strands, and Fig. 5A shows the results of permanganate probing of PIC1. In the absence of any repair factor both T(+1) and T(-1) were slightly reactive with permanganate, consistent with previous reports that T[6-4]T photoproducts unwind DNA in the immediate vicinity of the lesion (38, 39). Upon incubation of substrate with XPA, RPA, and XPC·HHR23B, the three factors that have been implicated in damage recognition (3, 4, 24), no additional hypersensitive sites appeared. This indicates that complexes that form with these factors do not substantially disrupt the duplex. In contrast, when TFIIH was included, the DNA was unwound in both directions as evidenced by permanganate hypersensitivity extending to T(+4) and T(-5) and by the enhanced sensitivity at T(+1) and T(-1) (Fig. 5A, lane 5). This unwinding was not caused by the nonspecific helicase action of TFIIH binding to the partially unwound T[6-4]T and enlarging it by the dual (3' to 5' and 5' to 3') helicase activities because the unwinding required XPA, RPA, and XPC·HHR23B in addition to TFIIH (Fig. 5A, lanes 6-8). The reaction also required ATP hydrolysis because it was inhibited by ATPgamma S; hence the unwinding had the characteristics of helicase action (lane 9). As expected, the combination of the four repair factors had no effect on the undamaged DNA control (lanes 11 and 12). Together these data lead us to conclude that XPA, RPA, XPC·HHR23B, and TFIIH make a specific complex with damaged DNA and unwind it around the lesion in both 5' and 3' directions more than 5 base pairs but less than 10 base pairs.


Fig. 4. Numbering scheme for thymines surrounding the lesion. Thymines 5' and 3' to the T[6-4]T are numbered as shown in both strands. The complete sequence of this 136-mer DNA has been published (34).

[View Larger Version of this Image (12K GIF file)]



Fig. 5. Unwinding of T[6-4]T in PIC1 is dependent on XPA, RPA, XPC·HHR23B, TFIIH, and ATP. Panel A, mixtures of XPA (20 ng), RPA (250 ng), and XPC·HHR23B (10 ng) were incubated with increasing amounts of TFIIH (lane 2, 0 ng; lane 3, 0.5 ng; lane 4, 3 ng; lane 5, 6 ng), and the T[6-4]T substrate (50 fmol) containing a 32P label at the 5'-terminus of the undamaged strand in 25 µl of excision reaction buffer with 2 mM ATP. After incubation at 30 °C for 60 min, unpaired thymines were probed using the permanganate chemical footprinting method. Lanes 5-8 contained 6 ng of TFIIH. In lane 9, the nonhydrolyzable analog of ATP, ATPgamma S, was added to the reaction mixture to a final concentration of 2 mM before permanganate treatment. A Maxam-Gilbert purine sequencing ladder of the substrate DNA is shown in lane 10. The thymines reactive with permanganate are indicated with open circles and those immediately external to the reactive thymines by closed circles. The permanganate probing experiment was performed with an unmodified substrate DNA of the same nucleotide sequence (lanes 11 and 12) under the indicated conditions. Panel B, diagram showing the "repair bubble" in PIC1.

[View Larger Version of this Image (77K GIF file)]


Since the excision assay suggests that PIC2 is more stable in PIC1, we wished to learn about the structure of the DNA in this complex. Under optimal conditions for formation of PIC1, we did not detect any effect of XPG (which defines the PIC2) on DNA sensitivity to permanganate. However, upon carrying out the KMnO4 reaction with limiting amounts of TFIIH, a clear XPG effect was observed. As shown in Fig. 6 both T(+4) and T-5) became more sensitive to KMnO4 oxidation with increasing concentrations of XPG. However, even with the highest concentrations of XPG used, the extent of unwinding in PIC2 was indistinguishable from that in PIC1. It thus appears that PIC1 is less stable than PIC2 and that by using high concentration of TFIIH, the equilibrium is shifted toward fully unwound conformation. The presence of XPG in the complex stabilizes it, possibly through its interaction with TFIIH (5, 30) and RPA (11). However, it is also known that the PIC2 is capable of making the 3'-incision (6). Thus, this apparent stabilization of the complex could be caused by KMnO4 hypersensitivity induced by a flap structure resulting from the 3'-incision. Hence, we wished to determine whether or not the PIC2 complex required the 3'-incision activity of XPG protein. For this purpose we used the XPG(D812A) mutant. This is an active-site mutant, and the D812A substitution completely abolishes the structure-specific endonuclease activity of XPG without affecting its other biochemical properties (31). When PIC2 was reconstituted with XPG(D812A), it exhibited the same properties as the PIC2 formed with the wild-type enzyme (Fig. 6, lane 9). Thus, it is concluded that binding of the XPG polypeptide to other proteins in the preincision complex stabilizes PIC1 and that the XPG nuclease activity is dispensable for this phenomenon.


Fig. 6. The XPG polypeptide plays a role in stabilizing the unwound DNA of PIC1 independent of its junction-cutting nuclease activity. Using the T[6-4]T substrate, permanganate probing was performed with the mixtures containing increasing amounts of XPG (lane 5, 0 ng; lane 6, 20 ng; lane 7, 40 ng; lane 8, 60 ng) under the condition of limiting TFIIH (0.5 ng) as in lane 3 of Fig. 5A. The mutant XPG(D812A) (40 ng), in place of wild-type XPG, was included in the reaction shown in lane 9. Lane 1 contained the substrate without any treatment; lane 2 contained the purine chemical sequencing ladder of the substrate. The KMnO4 reactive and nonreactive thymines are marked by open and closed circles, respectively.

[View Larger Version of this Image (53K GIF file)]


PIC3

The XPG and XPF·ERCC1 proteins are the 3'- and 5'-nuclease factors of human excision nuclease. In contrast to XPG, the pull-down experiments failed to reveal the presence of a preincision complex containing XPF·ERCC1. As the pull-down assay is a rather harsh method for isolating DNA·protein complexes, it was conceivable that such complexes did not survive the repeated washes. The unwinding assay provided us another opportunity to test whether such complexes form. Thus, we conducted KMnO4 probing with all repair factors except XPG using the same T[6-4]T substrate containing a 32P radiolabel at the 5'-terminus of the damaged strand. Consistent with what was observed with experiments performed with substrate radiolabeled in the undamaged strand (Figs. 5 and 6), with this substrate as well the combination of XPA, RPA, XPC·HHR23B, and TFIIH unwound t(-2), t(+2), and t(+6) (Fig. 7, lane 2). This result enabled us to narrow down the 5'-boundary of the excision bubble to be between t(+6) and T(+10). The addition of increasing amounts of XPF·ERCC1 did not affect the permanganate footprint, nor did it result in 5'-incision (lanes 3-5 and 9-10). These data support the conclusions from pull-down experiments that XPF·ERCC1 does not enter the excision nuclease complex before XPG and that the presence of XPG in the nuclease complex is required for XPF·ERCC1 to make the 5'-incision. This is consistent with the results obtained when the excision nuclease was reconstituted with the active-site mutant XPG protein (31).


Fig. 7. Detection of the bubble intermediate using substrate radiolabeled at the 5'-terminus of the strand containing T[6-4]T and the lack of XPF·ERCC1 made 5'-incision in the absence of XPG. Panel A, T[6-4]T substrate containing a 32P label at the 5'-terminus of the top (damaged) strand was incubated with the excision nuclease reconstituted with increasing amounts of XPF·ERCC1 (0, 20, 40, and 60 ng). After 90 min at 30 °C, half of each reaction was either probed by permanganate (lanes 2-5) or examined directly on an 8% denaturing polyacrylamide gel (lanes 8-11). Substrate without any treatment is shown in lane 7, whereas lane 1 shows the permanganate-oxidized substrate in the absence of repair proteins. Lane 6 contained a purine chemical sequencing ladder of the substrate. The amounts of XPA, RPA, XPC·HHR23B, and TFIIH in each reaction were identical to those in lane 5, Fig. 5A. Panel B, diagram indicating the thymines near the lesion in the damaged strand which were unpaired (open circles) or not (closed circles) as a result of the repair factors, summarizing the data in panel A.

[View Larger Version of this Image (54K GIF file)]


In fact, the active-site XPG mutant enabled us to identify a third excision nuclease complex, which we call PIC3. PIC3 forms when all of the repair factors are present. The excision nuclease assembled in the presence of the five repair factors plus XPG(D812A) does not make the 3'-incision (31) and yielded permanganate hypersensitivity pattern essentially identical to that of the PIC2 (Fig. 8, lanes 5 and 6). Thus the presence of XPF·ERCC1 in the complex does not affect the size of the excision bubble. In contrast, if instead of XPG(D812A) wild-type XPG is included in the reaction mixture, dual incisions take place, and a region extending from T(+18) to T(-5) becomes hypersensitive to permanganate. This result is in agreement with our earlier findings that upon dual incisions the human excision nuclease (in contrast with the bacterial excision nuclease) releases the excised oligomer and hence generates a single-stranded gap equal in size to the excised fragment (6). This explains the hypersensitivity of the T residues from T(+18) to T(-5) in the excision gap (Fig. 8, lane 7).


Fig. 8. PIC3 does not enlarge the repair bubble. Panel A, the reaction intermediates were probed by KMnO4. Lanes 1-4 contained control reactions as indicated; lane 5 contained PIC1 with saturating TFIIH (6 ng); lane 6 represents PIC3 formed with active-site XPG mutant (20 ng); lane 7 contained fully reconstituted excision nuclease. Panel B, a permanganate probe of postincision complex. Following dual incisions by the excision nuclease, the indicated thymines (open circles) are exposed in the single-stranded excision gap and prone to permanganate oxidation as evidenced by the reaction shown in lane 7 of panel A.

[View Larger Version of this Image (44K GIF file)]


Reactions with Model Substrates Mimicking Reaction Intermediates

The data presented so far show the formation of DNA intermediates with melted base pairs not exceeding 10 unpaired base pairs on either side of the lesion during the assembly of the excision repair nuclease. We wished to know whether by using premelted DNA (bubble structure) we could abrogate the requirement for some of the repair factors. We have shown previously that a substrate with a structure mimicking a transcription bubble stalled at a lesion, that is, a thymine dimer followed by a 10-nucleotide bubble, could be repaired in the absence of XPC·HHR23B (25). This finding provides support for the intermediacy of lesion-stalled transcription bubble in transcription-coupled repair and explains the XPC-independence of transcription-coupled repair (40, 41).

To investigate the role of unwinding in excision, we prepared three types of substrates. T<>T(3'-10) and T<>T(5'-10) contained 10 mismatched pairs in a row immediately next to a T<>T either at the 3'- or the 5'-side of the photodimer, respectively. The third substrate contained 20 mispaired bases with a T<>T in the center of the mismatched run (T<>T(20)) (Fig. 9A). In light of the role of TFIIH in unwinding the DNA in the PIC1 and PIC2, we were especially interested in whether or not the requirement for TFIIH could be circumvented by using unwound substrates. Excision assays were conducted with these substrates in the absence of individual factors that are known, or thought, to unwind and stabilize unwound DNA. Photodimers in all three substrates are repaired more efficiently than a T<>T in a nominal duplex DNA [T<>T(0)]. We had reported previously that T<>T(3'-10) is repaired faster than T<>T(0) (25), consistent with the notion that unwinding 3' to the lesion is on the pathway for repair. Here we show that T<>T(5'-10) is also repaired at a more rapid rate than T<>T(0), indicating that unwinding 5' to the lesion is also important for repair (Fig. 9B). Not surprisingly, T<>T(20) was also excised efficiently, further confirming the KMnO4 assay results that both 5' and 3' unwinding are on the pathway for repair. In addition, we observed that, as in the case of T<>T(3'-10), with T<>T(5'-10) and T<>T(20) substrates excision can occur without XPC·HHR23B. This finding raises the possibility that conditions such as replication, recombination, or other DNA dynamic events creating similar structures may enable cell to repair DNA in the absence of XPC. There is some indirect evidence that indeed such XPC-independent repair occurs in transcriptionally active chromosome domains (42). Most significantly, however, we find that TFIIH requirement can only very poorly be abrogated in substrate T<>T(20), which is more or less similar to the repair bubble we detected with permanganate (Fig. 9B, lane 22). Thus, it appears that TFIIH plays other roles in excision such as the interactions with XPA (29) and XPG (5, 30) proteins, in addition to its helix unwinding activity.


DISCUSSION

The basic reaction mechanism of human nucleotide excision repair and the proteins required for carrying out this reaction are relatively well understood (3, 4). However, the structures of DNA·protein complexes at various stages of the reaction, damage recognition, dual incision, and release of the excised oligomer are not known. Two general models have been advanced. One model proposes that all of the excision repair factors are assembled in the form of a repairosome capable of carrying out the entire excision reaction in yeast (43) or even the entire excision repair process including excision, repair synthesis, and ligation in humans (44). However, the repairosome proposed for yeast is incapable of carrying out damage excision, perhaps because of lack of RPA in complex with the RAD proteins. Indeed, a systematic study of the question has revealed the ready separation of repair proteins in yeast and provided strong evidence for sequential assembly (7, 8). Similarly, the protein preparation called human repairosome (44) contained many unrelated proteins and only a small fraction of the repair proteins (44). Again, the relative ease with which the repair proteins could be separated from human cell extracts (5, 6, 45) is evidence that sequential assembly is the modus operandi of excision repair in humans. Indeed, the best efficiency of excision has been accomplished by a reaction carried out with individually purified repair factors (6).

Although the preponderance of both experimental evidence and theoretical consideration are in favor of sequential assembly, the individual steps are not well understood. In particular, the damage recognition step remains rather ill defined (51). It has been reported that XPA (10), RPA (9, 13), or the combination of XPA and RPA (11, 12) is the damage recognition factors. Interestingly, none of these is capable of discriminating between cyclobutane thymine dimer-containing DNA and undamaged DNA. As thymine dimer is the most abundant lesion produced by UV and as it is repaired rather efficiently by human excision nuclease (6, 34), clearly XPA, RPA, or the XPA plus RPA combination cannot be considered the damage recognition factor or complex.

It seems that the optimal approach to understand the damage recognition step is to identify distinct DNA·protein complexes that form with various combinations of repair factors. Here we have identified three repair complexes that we have named preincision complexes 1, 2, and 3. We have been unable to detect specific binding of XPA, RPA, or the combination of the two to T<>T-containing DNA by DNase I footprinting (data not shown) or by permanganate footprinting. Instead, the earliest detectable complex in our study is PIC1 whose formation is absolutely dependent on XPA, RPA, XPC, and TFIIH. It is quite conceivable that XPA and RPA make a rather unstable complex that is stabilized by unwinding activity of TFIIH and the single-stranded DNA binding activity of XPC.

The second DNA·protein complex that was detected in this study is PIC2, which includes XPG in addition to the four repair factors required for generating PIC1. The main difference between PIC1 and PIC2 appears to be the increased stability of PIC2 conferred by the XPG protein. The fact that a normal 3'-incision (by XPG) can occur in this complex (6, 52) suggests that this is a functional intermediate on the pathway of assembly of excision nuclease.

A surprising finding in this study was the failure to detect a strong interaction between XPF·ERCC1 and PIC1 which forms in the presence of the XPA protein. It has been shown that XPA binds quite tightly to the XPF·ERCC1 complex (26, 28). In fact, this interaction is so strong and specific that an XPA affinity column is the main purification step for the XPF·ERCC1 complex (46). Furthermore, the XPF·ERCC1 complex is the subunit of the excision repair nuclease that carries out the 5'-incision (6, 20, 47). It is possible that within PIC1 the XPF·ERCC1 binding site of XPA is no longer accessible to these proteins. Whatever the reason for lack of binding of XPF·ERCC1, the practical consequence is that we cannot constitute a complex capable of making the 5'-incision in the absence of XPG. It is perhaps of relevance to note that in yeast the Rad14·(Rad1·Rad10) complex, which is the structural homolog of XPA·(XPF·ERCC1), can be isolated as a very stable complex. It is thought that in yeast the Rad14·(Rad1·Rad10) complex is essential for any damage-dependent nicking to occur, and hence an uncoupled 3'-incision is not observed in the absence of Rad1·Rad10 in the yeast excision nuclease system (7, 8). It appears that despite extensive structural and functional homologies between the human and yeast excision repair systems, some important differences in the mechanistic details do exist.

Another noteworthy finding of our studies is that the XPC·HHR23B complex is dispensable for excision of T<>T, not only from the T<>T(3'-10) and T<>T(20) but also from the T<>T(5'-10) substrate. This indicates that the presence of a single-stranded region of sufficient length around the dimer, regardless of its position relative to the dimer, makes XPC·HHR23B unnecessary for excision. This finding, combined with the high affinity of XPC to single-stranded DNA (23, 24), supports earlier suggestions that the function of XPC is to assist in DNA unwinding and stabilize the unwound structure (24). Clearly, the findings in this report constitute a useful lead on the XPC function in excision repair, which deserves further investigation.

During the course of this study, Evans et al. (48) reported on the unwinding of cisplatin 1,2-d(GpTpG) diadduct containing DNA in cell extracts of normal and excision repair-defective cell lines. The basic conclusion of that study, that excision repair in humans involves the formation of an "excision bubble," is in agreement with our findings. However, the two studies differ in several aspects. First, as summarized in Fig. 10 the size of the unwound region is less than 20 nucleotides in our study, but it was reported to be ~25 nucleotides by Evans et al. (48). The discrepancy could be due to the extensive unwinding caused by the cisplatin 1,3-d(GpTpG) lesion alone and the fact that the sequences around the lesion in the two studies are different. Second, Evans et al. (48) found unwinding around the lesion even in XPA mutant cell extracts whereas we find that unwinding in our defined system is totally dependent on XPA. Conceivably, DNA-binding proteins or helicases in the XPA cell extract not related to excision repair caused the unwinding of the DNA already unwound due to the cisplatin 1,3-d(GpTpG) lesion. Finally, Evans et al. (48) did not detect any effect of XPG on the unwinding reaction. However, the cell extract they used most likely contained a mutant XPG protein of full length (49), which could assemble with the other repair factors but was unable to carry out the incision reaction. Our studies with wild-type and active-site mutant XPG protein demonstrate the plausibility of this explanation and point to the advantage of studying the assembly reaction with purified proteins rather than cell extracts.


Fig. 10. Location and extent of the repair bubble and its relation to dual incision sites. The 5'-boundary of the observed bubble lies between T(+10) and t(+6), whereas the 3'-border is between T(-5) and T(-11). Thus the unpaired region as drawn reflects an approximation. The dual incision sites of this substrate have been determined in a previous study (34).

[View Larger Version of this Image (27K GIF file)]


Regarding the assembly of human excision nuclease our results allow us to propose the following minimal scheme (Fig. 11) involving at least three intermediates prior to the, usually concerted, dual incisions. It must be pointed out, however, that although we know the precise repair factors required for making the various preincision complexes, we do not know whether all of the proteins required for making a specific complex are present in that complex. It is conceivable that some of the proteins required for formation of PIC1 actually dissociate from the DNA·protein complex before PIC2 or PIC3 can form. In the Escherichia coli excision nuclease system, the (UvrA)2·(UvrB) complex binds to DNA, forming an intermediate that is analogous to "PIC1" detected for the human counterpart in this study. Subsequently UvrA dissociates, leaving behind a stable UvrB·DNA complex (PIC2), which in turn binds to UvrC (PIC3) to initiate the dual incision (for review, see Ref. 3). The function of UvrA is to promote the formation of a productive UvrB·DNA complex. This activity has been termed "molecular matchmaker" (50). It is not unreasonable to expect that one or more of the human excision nuclease constituents may act as molecular matchmakers. Further work on identifying the protein compositions of PIC1 to PIC3 is required to address this possibility.


Fig. 11. Reaction intermediates of human excision repair nuclease. Panel A, overview of nucleotide excision repair. The triangle stands for a nucleotide damage. Panel B, model of the excision nuclease mechanism highlighting the intermediates detected in this study.

[View Larger Version of this Image (23K GIF file)]



FOOTNOTES

*   This work was supported in part by National Institutes of Health Grant GM32833.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Dagger    Supported by Grant DRG-1319 from the Cancer Research Fund of the Damon Runyon-Walter Winchell Foundation, New York.
§   To whom correspondence should be addressed: Dept. of Biochemistry and Biophysics, Mary Ellen Jones Bldg., CB 7260, University of North Carolina School of Medicine, Chapel Hill, NC 27599. Tel.: 919-962-0115; Fax: 919-966-2852.
1   The abbreviations used are: XP, xeroderma pigmentosum; TFIIH, transcription factor IIH; HHR23B, human homolog B of Rad23; ERCC, excision repair cross-complementing; PIC, preincision complex; T[6-4]T, thymine-thymine [6-4] photoproduct; T<>T, cyclobutane thymine dimer; ATPgamma S, adenosine 5'-O-(thiotriphosphate).

ACKNOWLEDGEMENTS

We thank X. Zhao for the site-specifically damaged oligonucleotides. We acknowledge T. Bessho for recombinant XPF·ERCC1.


REFERENCES

  1. Cleaver, J. E., and Kraemer, K. H. (1989) in The Metabolic Basis of Inherited Disease (Scriver, C. R., Beaudet, A. L., Sly, W. S., and Valle, D., eds), Vol. 2, pp. 2949-2971, McGraw Hill, New York
  2. Friedberg, E. C., Walker, G. C., and Siede, W. (1995) DNA Repair and Mutagenesis, American Society for Microbiology, Washington, D. C.
  3. Sancar, A. (1996) Annu. Rev. Biochem. 65, 43-81 [CrossRef][Medline] [Order article via Infotrieve]
  4. Wood, R. D. (1996) Annu. Rev. Biochem. 65, 135-167 [CrossRef][Medline] [Order article via Infotrieve]
  5. Mu, D., Park, C.-H., Matsunaga, T., Hsu, D. S., Reardon, J. T., and Sancar, A. (1995) J. Biol. Chem. 270, 2415-2418 [Abstract/Free Full Text]
  6. Mu, D., Hsu, D. S., and Sancar, A. (1996) J. Biol. Chem. 271, 8285-8294 [Abstract/Free Full Text]
  7. Guzder, S. N., Habraken, Y., Sung, P., Prakash, P., and Prakash, S. (1995) J. Biol. Chem. 270, 12973-12976 [Abstract/Free Full Text]
  8. Guzder, S. N., Sung, P., Prakash, L., and Prakash, S. (1996) J. Biol. Chem. 271, 8903-8910 [Abstract/Free Full Text]
  9. Clugston, C. K., McLaughlin, K., Kenny, M. K., and Brown, R. (1992) Cancer Res. 52, 6375-6379 [Abstract/Free Full Text]
  10. Jones, C. J., and Wood, R. D. (1993) Biochemistry 32, 12096-12104 [CrossRef][Medline] [Order article via Infotrieve]
  11. He, Z., Henricksen, L. A., Wold, M. S., and Ingles, C. J. (1995) Nature 374, 566-569 [CrossRef][Medline] [Order article via Infotrieve]
  12. Li, L., Lu, X., Peterson, C. A., and Legerski, R. J. (1995) Mol. Cell. Biol. 15, 5396-5402 [Abstract]
  13. Burns, J. L., Guzder, S. N., Sung, P., Prakash, S., and Prakash, L. (1996) J. Biol. Chem. 271, 11607-11610 [Abstract/Free Full Text]
  14. Serizawa, H., Conaway, R. C., and Conaway, J. W. (1993) J. Biol. Chem. 268, 17300-17308 [Abstract/Free Full Text]
  15. Schaeffer, L., Roy, R., Humbert, S., Moncollin, V., Vermeulen, W., Hoeijmakers, J. H. J., Chambon, P., and Egly, J. M. (1993) Science 260, 58-63 [Abstract/Free Full Text]
  16. Drapkin, R., Reardon, J. T., Ansari, A., Huang, J.-C., Zawel, L., Ahn, K., Sancar, A., and Reinberg, D. (1994) Nature 368, 769-772 [CrossRef][Medline] [Order article via Infotrieve]
  17. Sung, P., Bailly, V., Weber, C., Thompson, L. H., Prakash, L., and Prakash, S. (1993) Nature 365, 852-855 [CrossRef][Medline] [Order article via Infotrieve]
  18. Hwang, J. R., Moncollin, V., Vermeulen, W., Seroz, T., van Vuuren, H., Hoeijmakers, J. H. J., and Egly, J. M. (1996) J. Biol. Chem. 271, 15898-15904 [Abstract/Free Full Text]
  19. O'Donovan, A., Davies, A. A., Moggs, J. G., West, S. C., and Wood, R. D. (1994) Nature 371, 432-435 [CrossRef][Medline] [Order article via Infotrieve]
  20. Matsunaga, T., Park, C.-H., Bessho, T., Mu, D., and Sancar, A. (1996) J. Biol. Chem. 271, 11047-11050 [Abstract/Free Full Text]
  21. Bessho, T., Sancar, A., Thompson, L. H., and Thelen, M. P. (1997) J. Biol. Chem. 272, 3833-3837 [Abstract/Free Full Text]
  22. Sijbers, A. M., de Laat, W. L., Ariza, R. R., Biggerstaff, M., Wei, Y.-F., Moggs, J. G., Carter, K. C., Shell, B. K., Evans, E., de Jong, M. C., Rademakers, S., de Rooij, J., Jaspers, N. G. J., Hoeijmakers, J. H. J., and Wood, R. D. (1996) Cell 86, 811-822 [CrossRef][Medline] [Order article via Infotrieve]
  23. Masutani, C., Sugasawa, K., Yanagisawa, J., Sonoyama, T., Ui, M., Enomoto, T., Takio, K., Tanaka, K., van der Spek, P. J., Bootsma, D., Hoeijmakers, J. H. J., and Hanaoka, F. (1994) EMBO J. 13, 1831-1843 [Medline] [Order article via Infotrieve]
  24. Reardon, J. T., Mu, D., and Sancar, A. (1996) J. Biol. Chem. 271, 19451-19456 [Abstract/Free Full Text]
  25. Mu, D., and Sancar, A. (1997) J. Biol. Chem. 272, 7570-7573 [Abstract/Free Full Text]
  26. Li, L., Elledge, S. J., Peterson, C. A., Bales, E. S., and Legerski, R. J. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 5012-5016 [Abstract/Free Full Text]
  27. Li, L., Peterson, C. A., Lu, X., and Legerski, R. (1995) Mol. Cell. Biol. 15, 1993-1998 [Abstract]
  28. Park, C.-H., and Sancar, A. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 5017-5021 [Abstract/Free Full Text]
  29. Park, C.-H., Mu, D., Reardon, J. T., and Sancar, A. (1995) J. Biol. Chem. 270, 4896-4902 [Abstract/Free Full Text]
  30. Iyer, N., Reagan, M. S., Wu, K.-J., Canagarajah, B., and Friedberg, E. C. (1996) Biochemistry 35, 2157-2167 [CrossRef][Medline] [Order article via Infotrieve]
  31. Wakasugi, M., Reardon, J. T., and Sancar, A. (1997) J. Biol. Chem. 272, 16030-16034 [Abstract/Free Full Text]
  32. Tanaka, K., Miura, N., Satokata, I., Miyamoto, I., Yoshida, M. C., Satoh, Y., Kondo, S., Yasui, A., Okayama, H., and Okada, Y. (1990) Nature 348, 73-76 [CrossRef][Medline] [Order article via Infotrieve]
  33. Henricksen, L. A., Umbricht, C. B., and Wold, M. S. (1994) J. Biol. Chem. 269, 11121-11132 [Abstract/Free Full Text]
  34. Mu, D., Tursun, M., Duckett, D. R., Drummond, J. T., Modrich, P., and Sancar, A. (1997) Mol. Cell. Biol. 17, 760-769 [Abstract]
  35. Smith, C. A., and Taylor, J.-S. (1993) J. Biol. Chem. 268, 11143-11151 [Abstract/Free Full Text]
  36. Borowiec, J. A., Zhang, L., Sasse-Dwight, S., and Gralla, J. D. (1987) J. Mol. Biol. 196, 101-111 [CrossRef][Medline] [Order article via Infotrieve]
  37. Sekiguchi, J., and Shuman, S. (1996) J. Biol. Chem. 271, 19436-19442 [Abstract/Free Full Text]
  38. Taylor, J.-S. (1994) Acc. Chem. Res. 27, 76-82 [CrossRef]
  39. Kim, J.-K., Patel, D., and Choi, B.-S. (1995) Photochem. Photobiol. 62, 44-50 [Medline] [Order article via Infotrieve]
  40. Venema, J., van Hoffen, A., Natarajan, A. T., van Zeeland, A. A., and Mullenders, L. H. F. (1990) Nucleic Acids Res. 18, 443-448 [Abstract/Free Full Text]
  41. Venema, J., van Hoffen, A., Karcagi, V., Natarajan, A. T., van Zeeland, A. A., and Mullenders, L. H. F. (1991) Mol. Cell. Biol. 11, 4128-4134 [Abstract/Free Full Text]
  42. Barsalou, L. S., Kantor, G. J., Deiss, D. M., and Hall, C. E. (1994) Mutation Res. 315, 43-45
  43. Svejstrup, J. Q., Wang, Z., Feaver, W. J., Wu, X., Bushnell, D. A., Donahue, T. F., Friedberg, E. C., and Kornberg, R. D. (1995) Cell 80, 21-28 [CrossRef][Medline] [Order article via Infotrieve]
  44. He, Z., and Ingles, C. J. (1997) Nucleic Acids Res. 25, 1136-1141 [Abstract/Free Full Text]
  45. Aboussekhra, A., Biggerstaff, M., Shivji, M. K. K., Vilpo, J. A., Moncollin, V., Podust, V. N., Proti<< c, M., Hübscher, U., Egly, J.-M., and Wood, R. D. (1995) Cell 80, 859-868 [CrossRef][Medline] [Order article via Infotrieve]
  46. Park, C.-H., Bessho, T., Matsunaga, M., and Sancar, A. (1995) J. Biol. Chem. 270, 22657-22660 [Abstract/Free Full Text]
  47. Matsunaga, T., Mu, D., Park, C.-H., Reardon, J. T., and Sancar, A. (1995) J. Biol. Chem. 270, 20862-20869 [Abstract/Free Full Text]
  48. Evans, E., Fellows, J., Coffer, A., and Wood, R. D. (1997) EMBO J. 16, 625-638 [CrossRef][Medline] [Order article via Infotrieve]
  49. Scherly, D., Nouspikel, T., Corlet, J., Ucla, C., Bairoch, A., and Clarkson, S. G. (1993) Nature 363, 182-185 [CrossRef][Medline] [Order article via Infotrieve]
  50. Sancar, A., and Hearst, J. E. (1993) Science 259, 1415-1420 [Abstract/Free Full Text]
  51. Gunz, D., Hess, M. T., and Naegeli, H. (1996) J. Biol. Chem. 271, 25089-25098 [Abstract/Free Full Text]
  52. Mu, D., and Sancar, A. (1997) Prog. Nucleic Acids Res. Mol. Biol. 56, 63-81 [Medline] [Order article via Infotrieve]

Volume 272, Number 46, Issue of November 14, 1997 pp. 28971-28979
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
CarcinogenesisHome page
K. Sugasawa
Xeroderma pigmentosum genes: functions inside and outside DNA repair
Carcinogenesis, March 1, 2008; 29(3): 455 - 465.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
G. Yasuda, R. Nishi, E. Watanabe, T. Mori, S. Iwai, D. Orioli, M. Stefanini, F. Hanaoka, and K. Sugasawa
In Vivo Destabilization and Functional Defects of the Xeroderma Pigmentosum C Protein Caused by a Pathogenic Missense Mutation
Mol. Cell. Biol., October 1, 2007; 27(19): 6606 - 6614.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. Hohl, I. Dunand-Sauthier, L. Staresincic, P. Jaquier-Gubler, F. Thorel, M. Modesti, S. G. Clarkson, and O. D. Scharer
Domain swapping between FEN-1 and XPG defines regions in XPG that mediate nucleotide excision repair activity and substrate specificity
Nucleic Acids Res., May 14, 2007; 35(9): 3053 - 3063.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
A. Zotter, M. S. Luijsterburg, D. O. Warmerdam, S. Ibrahim, A. Nigg, W. A. van Cappellen, J. H. J. Hoeijmakers, R. van Driel, W. Vermeulen, and A. B. Houtsmuller
Recruitment of the Nucleotide Excision Repair Endonuclease XPG to Sites of UV-Induced DNA Damage Depends on Functional TFIIH
Mol. Cell. Biol., December 1, 2006; 26(23): 8868 - 8879.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. T. Reardon and A. Sancar
Repair of DNA-polypeptide crosslinks by human excision nuclease.
PNAS, March 14, 2006; 103(11): 4056 - 4061.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
R. Nishi, Y. Okuda, E. Watanabe, T. Mori, S. Iwai, C. Masutani, K. Sugasawa, and F. Hanaoka
Centrin 2 Stimulates Nucleotide Excision Repair by Interacting with Xeroderma Pigmentosum Group C Protein
Mol. Cell. Biol., July 1, 2005; 25(13): 5664 - 5674.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Dunand-Sauthier, M. Hohl, F. Thorel, P. Jaquier-Gubler, S. G. Clarkson, and O. D. Scharer
The Spacer Region of XPG Mediates Recruitment to Nucleotide Excision Repair Complexes and Determines Substrate Specificity
J. Biol. Chem., February 25, 2005; 280(8): 7030 - 7037.
[Abstract] [Full Text] [PDF]